Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.
Snowden JA et al. Br J Haematol. 2017 Jan 20. doi: 10.1111/bjh.14514. [Epub ahead of print].
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
Beijers AJ et al. Ann Hematol. 2017 Jan 23. doi: 10.1007/s00277-017-2927-8. [Epub ahead of print].
Leukocytoclastic vasculitis with eosinophilic infiltration associated with thalidomide therapy for multiple myeloma: A case report.
Ichiyama S et al. Allergol Int. 2017 Jan 16. pii: S1323-8930(16)30177-0. doi: 10.1016/j.alit.2016.12.006. [Epub ahead of print].
Cryptococcosis in late stage multiple myeloma: consider it.
Bowcock SJ et al. Br J Haematol. 2017 Jan 20. doi: 10.1111/bjh.14496. [Epub ahead of print].
Cytomegalovirus reactivation accompanied by varicella zoster virus reactivation or reinfection in an adult patient of multiple myeloma during bortezomib therapy.
Hioki T et al. J Dermatol. 2017 Jan 20. doi: 10.1111/1346-8138.13744. [Epub ahead of print].
Chorioretinal folds in a patient with multiple myeloma treated with stem cell transplant.
Poon JS et al. Eur J Ophthalmol. 2017 Jan 16:0. doi: 10.5301/ejo.5000928. [Epub ahead of print].
Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma.
Choi WS et al. Maxillofac Plast Reconstr Surg. 2017 Jan 5;39(1):1. doi: 10.1186/s40902-016-0099-4. eCollection 2017.
Immune-Mediated Neuropathies following Autologous Stem Cell Transplantation for Multiple Myeloma: Case Series and Review of the Literature.
Mohyuddin GR et al. Acta Haematol. 2017 Jan 17;137(2):86-88. doi: 10.1159/000453390. [Epub ahead of print].
Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience.
Guo TJ et al. Chin Med J (Engl). 2017 20th Jan;130(2):239-241. doi: 10.4103/0366-6999.198017.
Emphysematous osteomyelitis due to Escherichia coli in multiple myeloma.
Park SS et al. Blood Res. 2016 Dec;51(4):224. doi: 10.5045/br.2016.51.4.224. Epub 2016 Dec 23.
Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study.
Anitha D et al. Medicine (Baltimore). 2017 Jan;96(2):e5825. doi: 10.1097/MD.0000000000005825.
Asymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma.
Tainsh LT et al. Cornea. 2017 Jan 11. doi: 10.1097/ICO.0000000000001139. [Epub ahead of print].
Disappearance of acquired hemophilia A after complete remission in a Multiple Myeloma patient.
Innao V et al. Turk J Haematol. 2017 Jan 12. doi: 10.4274/tjh.2016.0146. [Epub ahead of print].
Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma.
Zis P et al. Cerebellum Ataxias. 2017 Jan 5;4:1. doi: 10.1186/s40673-016-0060-4. eCollection 2017.
Healing of pathological fracture in a case of multiple myeloma.
Vaishya R et al. BMJ Case Rep. 2017 Jan 10;2017. pii: bcr2016218672. doi: 10.1136/bcr-2016-218672.
Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
Han X et al. BMC Cancer. 2017 Jan 9;17(1):40. doi: 10.1186/s12885-016-3037-z.
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Varma A et al. Biol Blood Marrow Transplant. 2017 Jan 4. pii: S1083-8791(17)30075-7. doi: 10.1016/j.bbmt.2017.01.005. [Epub ahead of print].
Pulmonary-renal syndrome as a clinical expression of multiple myeloma.
Gameiro J et al. Nefrologia. 2017 Jan 2. pii: S0211-6995(16)30194-1. doi: 10.1016/j.nefro.2016.10.020. [Epub ahead of print].
Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma.
Huang CT et al. BMC Infect Dis. 2017 Jan 6;17(1):33. doi: 10.1186/s12879-016-2155-1.
Isolated nerve plasmacytoma in a patient previously in systemic myeloma remission.
Menon P et al. Muscle Nerve. 2016 Dec 28. doi: 10.1002/mus.25544. [Epub ahead of print].
Subcutaneous Myeloma Deposit In The Region Of Arteriovenous Fistula.
Djuric P et al. Turk J Haematol. 2016 Dec 23. doi: 10.4274/tjh.2016.0335. [Epub ahead of print].
Hyponatremia in a multiple myeloma patient treated with bortezomib.
Shimazu Y et al. Hematol Oncol. 2016 Dec 22. doi: 10.1002/hon.2381. [Epub ahead of print].